Depression in diabetes

Author/s
Calum D. Moulton, Khalida Ismail
Citation
Issue 5 Winter 2018
CEPiP.2018.1.197-202
Abstract

Depression is twice as common in patients with diabetes; it is associated with an increased risk of diabetes complications and premature mortality. However, the mechanisms linking the two conditions are poorly understood and current treatments for depression frequently fail to improve diabetes outcomes. In addition to shared psychological factors, there is increasing evidence that biological mechanisms, such as elevated inflammation, may contribute to a common underlying mechanism for depression and type 2 diabetes. Improved understanding of such mechanisms has identified novel targets for treatment that may improve depression and diabetes simultaneously. In the longer term, such pathways may provide targets to prevent the onset of type 2 diabetes in depression altogether.

Cite as: Cutting Edge Psychiatry in Practice 2018, 5(1):197-202; https://doi.org/10.65031/hzfh3190

References

  1. Anderson RJ, Freedland KE, Clouse RE, Lustman PJ. The prevalence of comorbid depression in adults with diabetes: a meta-analysis. Diabetes Care. 2001 Jun 1;24(6):1069-78. https://doi.org/10.2337/diacare.24.6.1069
  2. De Groot M, Anderson R, Freedland KE, Clouse RE, Lustman PJ. Association of depression and diabetes complications: a meta-analysis. Psychosomatic Medicine. 2001 Jul 1;63(4):619-30. https://doi.org/10.1097/00006842-200107000-00015
  3. Katon WJ, Rutter C, Simon G, Lin EH, Ludman E, Ciechanowski P, Kinder L, Young B, Von Korff M. The association of comorbid depression with mortality in patients with type 2 diabetes. Diabetes Care. 2005 Nov 1;28(11):2668-72. https://doi.org/10.2337/diacare.28.11.2668
  4. Carper MM, Traeger L, Gonzalez JS, Wexler DJ, Psaros C, Safren SA. The differential associations of depression and diabetes distress with quality of life domains in type 2 diabetes. Journal of Behavioral Medicine. 2014 Jun 1;37(3):501-10. https://doi.org/10.1007/s10865-013-9505-x
  5. Kessler RC, Amminger GP, Aguilar‐Gaxiola S, Alonso J, Lee S, Ustun TB. Age of onset of mental disorders: a review of recent literature. Current Opinion in Psychiatry. 2007 Jul;20(4):359. https://doi.org/10.1097/yco.0b013e32816ebc8c
  6. Moulton CD, Costafreda SG, Horton P, Ismail K, Fu CH. Meta-analyses of structural regional cerebral effects in type 1 and type 2 diabetes. Brain Imaging and Behavior. 2015 Dec 1;9(4):651-62. https://doi.org/10.1007/s11682-014-9348-2
  7. Snoek FJ, Bremmer MA, Hermanns N. Constructs of depression and distress in diabetes: time for an appraisal. The Lancet Diabetes & Endocrinology. 2015 Jun 1;3(6):450-60. https://doi.org/10.1016/s2213-8587(15)00135-7
  8. Schmitz N, Gariépy G, Smith KJ, Clyde M, Malla A, Boyer R, Strychar I, Lesage A, Wang J. Recurrent subthreshold depression in type 2 diabetes: an important risk factor for poor health outcomes. Diabetes Care. 2014 Apr 1;37(4):970-8. https://doi.org/10.2337/dc13-1832
  9. Katon W, Lyles CR, Parker MM, Karter AJ, Huang ES, Whitmer RA. Association of depression with increased risk of dementia in patients with type 2 diabetes: the Diabetes and Aging Study. Archives of General Psychiatry. 2012 Apr 1;69(4):410-7. https://doi.org/10.1001/archgenpsychiatry.2011.154
  10. Sullivan MD, Katon WJ, Lovato LC, Miller ME, Murray AM, Horowitz KR, Bryan RN, Gerstein HC, Marcovina S, Akpunonu BE, Johnson J. Association of depression with accelerated cognitive decline among patients with type 2 diabetes in the ACCORD-MIND trial. JAMA Psychiatry. 2013 Oct 1;70(10):1041-7. https://doi.org/10.1001/jamapsychiatry.2013.1965
  11. Krass I, Schieback P, Dhippayom T. Adherence to diabetes medication: a systematic review. Diabetic Medicine. 2015 Jun;32(6):725-37. https://doi.org/10.1111/dme.12651
  12. Lustman PJ, Anderson RJ, Freedland KE, De Groot M, Carney RM, Clouse RE. Depression and poor glycemic control: a meta-analytic review of the literature. Diabetes Care. 2000 Jul 1;23(7):934-42. https://doi.org/10.2337/diacare.23.7.934
  13. Fisher L, Mullan JT, Arean P, Glasgow RE, Hessler D, Masharani U. Diabetes distress but not clinical depression or depressive symptoms is associated with glycemic control in both cross-sectional and longitudinal analyses. Diabetes Care. 2010 Jan 1;33(1):23-8. https://doi.org/10.2337/dc09-1238
  14. Palta P, Golden SH, Teresi JA, Palmas W, Trief P, Weinstock RS, Shea S, Manly JJ, Luchsinger JA. Depression is not associated with diabetes control in minority elderly. Journal of Diabetes and its Complications. 2014 Nov 1;28(6):798-804. https://doi.org/10.1016/j.jdiacomp.2014.06.014
  15. Nouwen A, Winkley K, Twisk J, Lloyd CE, Peyrot M, Ismail K, Pouwer F. European Depression in Diabetes (EDID) Research Consortium. Type 2 diabetes mellitus as a risk factor for the onset of depression: a systematic review and meta-analysis. Diabetologia. 2010;53(12):2480-6. https://doi.org/10.1007/s00125-010-1874-x
  16. Mezuk B, Eaton WW, Albrecht S, Golden SH. Depression and type 2 diabetes over the lifespan: a meta-analysis. Diabetes Care. 2008 Dec 1;31(12):2383-90. https://doi.org/10.2337/dc08-0985
  17. Cole J, Costafreda SG, McGuffin P, Fu CH. Hippocampal atrophy in first episode depression: a meta-analysis of magnetic resonance imaging studies. Journal of Affective Disorders. 2011 Nov 1;134(1-3):483-7. https://doi.org/10.1016/j.jad.2011.05.057
  18. Samaan Z, Garasia S, Gerstein HC, Engert JC, Mohan V, Diaz R, Anand SS, Meyre D. Lack of association between type 2 diabetes and major depression: epidemiologic and genetic evidence in a multiethnic population. Translational Psychiatry. 2015 Aug;5(8):e618. https://doi.org/10.1038/tp.2015.113
  19. Kan C, Pedersen NL, Christensen K, Bornstein SR, Licinio J, MacCabe JH, Ismail K, Rijsdijk F. Genetic overlap between type 2 diabetes and depression in Swedish and Danish twin registries. Molecular Psychiatry. 2016 Jul;21(7):903. https://doi.org/10.1038/mp.2016.28
  20. Khandaker GM, Pearson RM, Zammit S, Lewis G, Jones PB. Association of serum interleukin 6 and C-reactive protein in childhood with depression and psychosis in young adult life: a population-based longitudinal study. JAMA Psychiatry. 2014 Oct 1;71(10):1121-8. https://doi.org/10.1001/jamapsychiatry.2014.1332
  21. Pickup JC, Crook MA. Is type II diabetes mellitus a disease of the innate immune system? Diabetologia. 1998 Sep 1;41(10):1241-8. https://doi.org/10.1007/s001250051058
  22. Pickup JC, Mattock MB. Activation of the innate immune system as a predictor of cardiovascular mortality in type 2 diabetes mellitus. Diabetic Medicine. 2003 Sep;20(9):723-6. https://doi.org/10.1046/j.1464-5491.2003.00990.x
  23. Goldfine AB, Fonseca V, Jablonski KA, Chen YD, Tipton L, Staten MA, Shoelson SE. Salicylate (salsalate) in patients with type 2 diabetes: a randomized trial. Annals of Internal Medicine. 2013 Jul 2;159(1):1-12. https://doi.org/10.7326/0003-4819-159-1-201307020-00003
  24. Na KS, Lee KJ, Lee JS, Cho YS, Jung HY. Efficacy of adjunctive celecoxib treatment for patients with major depressive disorder: a meta-analysis. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 2014 Jan 3;48:79-85. https://doi.org/10.1016/j.pnpbp.2013.09.006
  25. Laake JP, Stahl D, Amiel SA, Petrak F, Sherwood RA, Pickup JC, Ismail K. The association between depressive symptoms and systemic inflammation in people with type 2 diabetes: findings from the South London Diabetes Study. Diabetes Care. 2014 May 14:DC_132522. https://doi.org/10.2337/dc13-2522
  26. Stetler C, Miller GE. Depression and hypothalamic-pituitary-adrenal activation: a quantitative summary of four decades of research. Psychosomatic Medicine. 2011 Feb 1;73(2):114-26. https://doi.org/10.1097/psy.0b013e31820ad12b
  27. Rosmond R, Björntorp P. The hypothalamic–pituitary–adrenal axis activity as a predictor of cardiovascular disease, type 2 diabetes and stroke. Journal of Internal Medicine. 2000 Feb;247(2):188-97. https://doi.org/10.1046/j.1365-2796.2000.00603.x
  28. Teicher MH, Andersen SL, Polcari A, Anderson CM, Navalta CP, Kim DM. The neurobiological consequences of early stress and childhood maltreatment. Neuroscience & Biobehavioral Reviews. 2003 Mar 31;27(1):33-44. https://doi.org/10.1016/s0149-7634(03)00007-1
  29. Nikkheslat N, Zunszain PA, Horowitz MA, Barbosa IG, Parker JA, Myint AM, Schwarz MJ, Tylee AT, Carvalho LA, Pariante CM. Insufficient glucocorticoid signaling and elevated inflammation in coronary heart disease patients with comorbid depression. Brain, Behavior and Immunity. 2015 Aug 1;48:8-18. https://doi.org/10.1016/j.bbi.2013.07.090
  30. Lustman PJ, Clouse RE, Nix BD, Freedland KE, Rubin EH, McGill JB, Williams MM, Gelenberg AJ, Ciechanowski PS, Hirsch IB. Sertraline for prevention of depression recurrence in diabetes mellitus: a randomized, double-blind, placebo-controlled trial. Archives of General Psychiatry. 2006 May 1;63(5):521-9. https://doi.org/10.1001/archpsyc.63.5.521
  31. Echeverry D, Duran P, Bonds C, Lee M, Davidson MB. Effect of pharmacological treatment of depression on A1C and quality of life in low-income Hispanics and African Americans with diabetes: a randomized, double-blind, placebo-controlled trial. Diabetes Care. 2009 Dec 1;32(12):2156-60. https://doi.org/10.2337/dc09-0785
  32. Hermanns N, Schmitt A, Gahr A, Herder C, Nowotny B, Roden M, Ohmann C, Kruse J, Haak T, Kulzer B. The effect of a diabetes-specific cognitive behavioral treatment program (DIAMOS) for patients with diabetes and subclinical depression: results of a randomized controlled trial. Diabetes Care. 2015 Jan 7:dc141416. https://doi.org/10.2337/dc14-1416
  33. Safren SA, Gonzalez JS, Wexler DJ, Psaros C, Delahanty LM, Blashill AJ, Margolina AI, Cagliero E. A randomized controlled trial of cognitive behavioral therapy for adherence and depression (CBT-AD) in patients with uncontrolled type 2 diabetes. Diabetes Care. 2014 Mar 1;37(3):625-33. https://doi.org/10.2337/dc13-0816
  34. Katon WJ, Von Korff M, Lin EH, Simon G, Ludman E, Russo J, Ciechanowski P, Walker E, Bush T. The pathways study: A randomized trial of collaborative care in patients with diabetesand depression. Archives of General Psychiatry. 2004 Oct 1;61(10):1042-9. https://doi.org/10.1001/archpsyc.61.10.1042
  35. Petrak F, Baumeister H, Skinner TC, Brown A, Holt RI. Depression and diabetes: treatment and health-care delivery. The Lancet Diabetes & Endocrinology. 2015 Jun 1;3(6):472-85. https://doi.org/10.1016/s2213-8587(15)00045-5
  36. Atlantis E, Fahey P, Foster J. Collaborative care for comorbid depression and diabetes: a systematic review and meta-analysis. BMJ Open. 2014 Apr 1;4(4):e004706. https://doi.org/10.1136/bmjopen-2013-004706
  37. Sarris J, O’Neil A, Coulson CE, Schweitzer I, Berk M. Lifestyle medicine for depression. BMC Psychiatry. 2014 Dec;14(1):107. https://doi.org/10.1186/1471-244x-14-107
  38. Harald B, Gordon P. Meta-review of depressive subtyping models. Journal of Affective Disorders. 2012 Jul 1;139(2):126-40. https://doi.org/10.1016/j.jad.2011.07.015
  39. Bruce DG, Davis WA, Dragovic M, Davis TM, Starkstein SE. Comorbid anxiety and depression and their impact on cardiovascular disease in type 2 diabetes: the Fremantle Diabetes Study phase II. Depression and Anxiety. 2016 Oct;33(10):960-6. https://doi.org/10.1002/da.22523
  40. Moulton CD, Pickup JC, Amiel SA, Winkley K, Ismail K. Investigating incretin-based therapies as a novel treatment for depression in type 2 diabetes: Findings from the South London Diabetes (SOUL-D) Study. Primary Care Diabetes. 2016 Apr 1;10(2):156-9. https://doi.org/10.1016/j.pcd.2015.06.003